Moerae Matrix, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2007-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://moeraematrix.com
Clinical Trials
3
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Phase 1a Study in Healthy Smokers to Investigate the Effect With MMI-0100 on Airway Inflammation in Induced Sputum After Challenge With Inhaled Lipopolysaccharide
Phase 1
- Conditions
- Acute Inflammatory Response to Non-antigenic Stimulus
- Interventions
- Drug: Placebo
- First Posted Date
- 2015-08-04
- Last Posted Date
- 2017-04-07
- Lead Sponsor
- Moerae Matrix, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT02515396
- Locations
- 🇬🇧
Respiratory Clinical Trials, The Heart Lung Centre, London, England, United Kingdom
News
No news found